{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:49:00Z","timestamp":1788187740793,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"am","delay-in-days":373,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100011104","name":"Universitat Aut\u00f2noma de Barcelona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["U01HL134764"],"award-info":[{"award-number":["U01HL134764"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["P01 HL160476"],"award-info":[{"award-number":["P01 HL160476"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL131017"],"award-info":[{"award-number":["R01HL131017"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL149137"],"award-info":[{"award-number":["R01HL149137"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.actbio.2025.08.050","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T23:25:25Z","timestamp":1756509925000},"page":"648-658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Human induced pluripotent stem cell-derived nanovesicles for the treatment of ischemic limb disease"],"prefix":"10.1016","volume":"205","author":[{"given":"Yuhua","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1768-6379","authenticated-orcid":false,"given":"Akazha","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijay","family":"Guragain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2028-7590","authenticated-orcid":false,"given":"Bing","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7036-0384","authenticated-orcid":false,"given":"Yu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2025.08.050_bib0001","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002938","article-title":"Critical limb ischemia: current trends and future directions","volume":"5","author":"Teraa","year":"2016","journal-title":"J. Am. Heart. Assoc."},{"key":"10.1016\/j.actbio.2025.08.050_bib0002","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.001946","article-title":"Management of critical limb ischemia","volume":"9","author":"Kinlay","year":"2016","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2025.08.050_bib0003","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.jvs.2015.07.065","article-title":"The natural history of untreated severe or critical limb ischemia","volume":"62","author":"Abu Dabrh","year":"2015","journal-title":"J. Vasc. Surg."},{"issue":"Suppl 2","key":"10.1016\/j.actbio.2025.08.050_bib0004","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S1078-5884(11)60009-9","article-title":"Chapter I: definitions, epidemiology, clinical presentation and prognosis","volume":"42","author":"Becker","year":"2011","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"10.1016\/j.actbio.2025.08.050_bib0005","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0140-6736(05)67704-5","article-title":"Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial","volume":"366","author":"Adam","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.actbio.2025.08.050_bib0006","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","article-title":"One-year cardiovascular event rates in outpatients with atherothrombosis","volume":"297","author":"Steg","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.actbio.2025.08.050_bib0007","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.114.012913","volume":"131","author":"Teraa","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.actbio.2025.08.050_bib0008","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s13287-022-03043-3","article-title":"Mesenchymal stem cells for critical limb ischemia: their function, mechanism, and therapeutic potential","volume":"13","author":"Lozano Navarro","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.actbio.2025.08.050_bib0009","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(11)60394-2","article-title":"Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia","volume":"377","author":"Belch","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.actbio.2025.08.050_bib0010","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/mt.2008.33","article-title":"Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia","volume":"16","author":"Nikol","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.actbio.2025.08.050_bib0011","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0140-6736(96)03361-2","article-title":"Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb","volume":"348","author":"Isner","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.actbio.2025.08.050_bib0012","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1161\/01.CIR.97.12.1114","article-title":"Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia","volume":"97","author":"Baumgartner","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.actbio.2025.08.050_bib0013","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.ymthe.2019.10.017","article-title":"Randomized, double-blind, placebo-controlled phase II study of hepatocyte growth factor in the treatment of critical limb ischemia","volume":"27","author":"Gu","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.actbio.2025.08.050_bib0014","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ejvs.2024.07.016","article-title":"Recombinant Human hepatocyte growth factor plasmids for treating patients with chronic limb threatening ischaemia: a systematic review and meta-analysis","volume":"68","author":"Di","year":"2024","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"10.1016\/j.actbio.2025.08.050_bib0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/01.HYP.0000136394.08900.ed","article-title":"Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease","volume":"44","author":"Morishita","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.actbio.2025.08.050_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.141730","article-title":"Multibiofunctional TFEB-engineered endothelial progenitor cell-derived extracellular vesicles\/hydrogel system for rescuing critical limb ischemia","volume":"460","author":"Zhao","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.actbio.2025.08.050_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126375","article-title":"Endothelial progenitor cell-derived extracellular vesicles: potential therapeutic application in tissue repair and regeneration","volume":"22","author":"Terriaca","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.actbio.2025.08.050_bib0018","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jconrel.2017.08.022","article-title":"Extracellular vesicles from mesenchymal stem cells activates VEGF receptors and accelerates recovery of hindlimb ischemia","volume":"264","author":"Gangadaran","year":"2017","journal-title":"J. Control Release"},{"key":"10.1016\/j.actbio.2025.08.050_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115167","article-title":"Mesenchymal stem cells derived extracellular vesicles: a promising nanomedicine for drug delivery system","volume":"203","author":"Rezaie","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.actbio.2025.08.050_bib0020","first-page":"585","article-title":"Human induced pluripotent stem cell derived nanovesicles for cardiomyocyte protection and proliferation","volume":"50","author":"Wei","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.actbio.2025.08.050_bib0021","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s44222-024-00219-9","article-title":"Genetically engineered hypoimmunogenic cell therapy","volume":"2","author":"Hotta","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.actbio.2025.08.050_bib0022","doi-asserted-by":"crossref","first-page":"7879","DOI":"10.7150\/thno.56757","article-title":"Thymosin beta4 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell-derived cardiomyocytes in a porcine model of acute myocardial infarction","volume":"11","author":"Tan","year":"2021","journal-title":"Theranostics."},{"key":"10.1016\/j.actbio.2025.08.050_bib0023","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50980-w","article-title":"Non-viral vector based gene transfection with human induced pluripotent stem cells derived cardiomyocytes","volume":"9","author":"Tan","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2025.08.050_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.667252","article-title":"Diabetic endothelial cells differentiated from patient iPSCs show dysregulated glycine homeostasis and senescence associated phenotypes","volume":"9","author":"Su","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.actbio.2025.08.050_bib0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13287-021-02687-x","article-title":"Thymosin beta-4 improves endothelial function and reparative potency of diabetic endothelial cells differentiated from patient induced pluripotent stem cells","volume":"13","author":"Su","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.actbio.2025.08.050_bib0026","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/cvr\/cvaa215","article-title":"Angiopoietin-1 enhanced myocyte mitosis, engraftment, and the reparability of hiPSC-CMs for treatment of myocardial infarction","volume":"117","author":"Tao","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.actbio.2025.08.050_bib0027","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1186\/s13287-024-04053-z","article-title":"Dynamic three dimensional environment for efficient and large scale generation of smooth muscle cells from hiPSCs","volume":"15","author":"Green","year":"2024","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.actbio.2025.08.050_bib0028","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s13287-018-1061-4","article-title":"The prostaglandin H2 analog U-46619 improves the differentiation efficiency of human induced pluripotent stem cells into endothelial cells by activating both p38MAPK and ERK1\/2 signaling pathways","volume":"9","author":"Su","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.actbio.2025.08.050_bib0029","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/cvr\/cvad004","article-title":"Cardiac muscle patches containing four types of cardiac cells derived from human pluripotent stem cells improve recovery from cardiac injury in mice","volume":"119","author":"Lou","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.actbio.2025.08.050_bib0030","first-page":"69","article-title":"Management of non-reconstructable critical limb ischemia","volume":"34","author":"Patel","year":"2019","journal-title":"Surg. Technol. Int."},{"key":"10.1016\/j.actbio.2025.08.050_bib0031","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/CIRCRESAHA.124.325562","article-title":"Follistatin from hiPSC-cardiomyocytes promotes myocyte proliferation in pigs with postinfarction LV remodeling","volume":"136","author":"Wei","year":"2025","journal-title":"Circ. Res."},{"key":"10.1016\/j.actbio.2025.08.050_bib0032","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.transproceed.2003.11.001","article-title":"Effectiveness of transient immunosuppression using cyclosporine for xenomyoblast transplantation for cardiac repair","volume":"36","author":"Haider","year":"2004","journal-title":"TransPlant Proc."},{"key":"10.1016\/j.actbio.2025.08.050_bib0033","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","article-title":"Hippo pathway in organ size control, tissue homeostasis, and cancer","volume":"163","author":"Yu","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.actbio.2025.08.050_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119919","article-title":"Revascularization and limb salvage following critical limb ischemia by nanoceria-induced ref-1\/APE1-dependent angiogenesis","volume":"242","author":"Park","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2025.08.050_bib0035","series-title":"Oxidative Stress and Biomaterials","first-page":"35","article-title":"Chapter two - oxidative stress, inflammation, and disease","author":"Chatterjee","year":"2016"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125006440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125006440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:26:03Z","timestamp":1780039563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706125006440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":35,"alternative-id":["S1742706125006440"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2025.08.050","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human induced pluripotent stem cell-derived nanovesicles for the treatment of ischemic limb disease","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2025.08.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}